Pacific Shuanglin Bio pharmacy Co Ltd (000403.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE000000F14

Price

9.45 CNY

Market cap

8.98 bn CNY

P/E (2025)

21.42

P/S (2025)

3.41

Dividend yield

1.59 %

Net margin

15.93 %

Return on equity (ROE)

5.18 %

Return on assets (ROA)

4.43 %

Pacific Shuanglin Bio pharmacy Co Ltd financials

Fiscal year	2024	2025
Revenue	2.65 bn CNY	2.63 bn CNY
Gross profit	1.30 bn CNY	1.09 bn CNY
Operating income	880.31 m CNY	586.54 m CNY
EBIT	793.13 m CNY	518.49 m CNY
Net income	745.32 m CNY	419.27 m CNY
Diluted EPS – continuing operations	1.02 CNY	0.44 CNY

Full history since 1993, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Pacific Shuanglin Bio pharmacy Co Ltd

Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of blood products in China and internationally. The company offers human serum albumin, human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen, lyophilized intravenous immunoglobulin (pH4), hepatitis B immunoglobulin (pH4), and human prothrombin complex concentrate, as well as intravenous cytomegalovirus immunoglobulin and intravenous respiratory syncytial virus immunoglobulin. It is also involved in blood acquisition; plasma collection; consulting; trading; investment activities; and technology promotion and application services. The company was formerly known as Southern Shuanglin Bio-pharmacy Co., Ltd. and changed its name to Pacific Shuanglin Bio-pharmacy Co., Ltd. in April 2021. Pacific Shuanglin Bio-pharmacy Co., Ltd. was founded in 1993 and is headquartered in Taiyuan, China.

More stocks

PROG Holdings, Inc. (PRG)
Riyue Heavy Industry Co Ltd (603218.SS)
Valeura Energy Inc (VLE.TO)
Vanchip (Tianjin) Technology Co. Ltd. A (688153.SS)
Ratos AB (RATO B.ST)
Lotus Pharmaceutical Co Ltd (1795.TW)
Spire Healthcare Group PLC (SPI.L)
Nutex Health Inc. (NUTX)
MEDICAL PROPERTIES TRUST INC (MPT)
HERBALIFE LTD. (HLF)
Scientex Bhd (4731.KL)
Lotte Rental Co Ltd (089860.KS)

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.